COO
The Cooper Companies, Inc. NASDAQ Listed Jan 21, 1983$65.91
+1.32%
vs $65.05
Mkt Cap $13.2B
52w Low $58.98
27.3% of range
52w High $84.32
50d MA $64.29
200d MA $72.66
P/E (TTM)
35.2x
EV/EBITDA
14.7x
P/B
1.6x
Debt/Equity
0.3x
ROE
4.8%
P/FCF
30.4x
RSI (14)
63.70
ATR (14)
$1.71
Beta
1.07
50d MA
$64.29
200d MA
$72.66
Avg Volume
3.2M
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
6101 Bollinger Canyon Road · San Ramon, CA 94583 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | AMC | 1.10 | 1.21 | +10.0% | 62.02 | +5.2% | +8.6% | -0.8% | +2.7% | -1.4% | -0.3% | — |
| Mar 5, 2026 | AMC | 1.03 | 1.10 | +6.8% | 80.20 | -4.0% | -4.6% | -1.0% | -1.9% | -0.9% | -3.0% | — |
| Dec 4, 2025 | AMC | 1.11 | 1.15 | +3.6% | 77.03 | +16.4% | +5.7% | -4.1% | +0.6% | +2.8% | +1.7% | — |
| Aug 27, 2025 | AMC | 1.07 | 1.10 | +2.8% | 74.11 | -16.0% | -12.9% | +4.4% | -3.1% | +2.8% | +1.3% | — |
| May 29, 2025 | AMC | 0.93 | 0.96 | +3.4% | 79.96 | -10.0% | -14.6% | -1.9% | -0.1% | +0.8% | +5.6% | — |
| Mar 6, 2025 | AMC | 0.91 | 0.92 | +0.7% | 90.98 | -5.3% | -6.6% | -6.0% | +1.4% | -2.4% | -1.7% | — |
| Dec 5, 2024 | AMC | 1.00 | 1.04 | +4.0% | 103.23 | -3.7% | -4.4% | +0.6% | -0.2% | +0.2% | -2.6% | — |
| Aug 28, 2024 | AMC | 0.91 | 0.96 | +5.4% | 94.54 | +10.1% | +11.8% | +0.0% | +0.3% | -0.5% | +0.9% | — |
| May 30, 2024 | AMC | 0.83 | 0.85 | +2.5% | 90.23 | +6.4% | +4.5% | +0.4% | -0.2% | -0.3% | +1.1% | — |
| Feb 29, 2024 | AMC | 0.78 | 0.85 | +8.6% | 93.60 | +9.0% | +9.2% | +0.6% | -1.3% | +0.4% | +0.2% | — |
| Dec 7, 2023 | AMC | 0.87 | 0.87 | +0.0% | 86.24 | -0.3% | -2.9% | +1.3% | +0.3% | +4.5% | +3.3% | — |
| Aug 30, 2023 | AMC | 0.84 | 0.84 | +0.0% | 95.21 | -0.7% | -2.8% | -1.4% | -3.4% | +1.3% | -0.8% | — |
| Jun 1, 2023 | AMC | 0.75 | 0.77 | +2.7% | 93.55 | -3.8% | -4.7% | -0.8% | -0.3% | -0.5% | -0.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5 | Needham | Reiterates | Buy | $86 | $62.02 | $65.24 | +5.2% | +8.6% | -0.8% | +2.7% | -1.4% | -0.3% |
| Mar 6 | Citigroup | Maintains | Neutral → Neutral | — | $80.20 | $77.00 | -4.0% | -4.6% | -1.0% | -1.9% | -0.9% | -3.0% |
| Mar 6 | Needham | Maintains | Buy → Buy | — | $80.20 | $77.00 | -4.0% | -4.6% | -1.0% | -1.9% | -0.9% | -3.0% |
| Mar 6 | Barclays | Maintains | Overweight → Overweight | — | $80.20 | $77.00 | -4.0% | -4.6% | -1.0% | -1.9% | -0.9% | -3.0% |
| Feb 3 | Needham | Maintains | Buy → Buy | — | $80.65 | $80.39 | -0.3% | -1.6% | +2.0% | -1.0% | +2.5% | -0.8% |
| Jan 26 | Barclays | Maintains | Overweight → Overweight | — | $81.29 | $81.52 | +0.3% | -0.5% | -0.2% | -0.3% | -0.1% | +1.3% |
| Dec 8 | Citigroup | Maintains | Neutral → Neutral | — | $81.40 | $81.70 | +0.4% | -4.1% | +0.6% | +2.8% | +1.7% | -0.0% |
| Dec 8 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $81.40 | $81.70 | +0.4% | -4.1% | +0.6% | +2.8% | +1.7% | -0.0% |
| Dec 8 | Goldman Sachs | Maintains | Sell → Sell | — | $81.40 | $81.70 | +0.4% | -4.1% | +0.6% | +2.8% | +1.7% | -0.0% |
| Dec 5 | JP Morgan | Maintains | Neutral → Neutral | — | $77.03 | $89.66 | +16.4% | +5.7% | -4.1% | +0.6% | +2.8% | +1.7% |
| Dec 5 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $77.03 | $89.66 | +16.4% | +5.7% | -4.1% | +0.6% | +2.8% | +1.7% |
| Dec 5 | Mizuho | Maintains | Outperform → Outperform | — | $77.03 | $89.66 | +16.4% | +5.7% | -4.1% | +0.6% | +2.8% | +1.7% |
| Dec 5 | Baird | Maintains | Outperform → Outperform | — | $77.03 | $89.66 | +16.4% | +5.7% | -4.1% | +0.6% | +2.8% | +1.7% |
| Dec 5 | Stifel | Maintains | Buy → Buy | — | $77.03 | $89.66 | +16.4% | +5.7% | -4.1% | +0.6% | +2.8% | +1.7% |
| Dec 5 | Piper Sandler | Maintains | Overweight → Overweight | — | $77.03 | $89.66 | +16.4% | +5.7% | -4.1% | +0.6% | +2.8% | +1.7% |
| Dec 5 | Needham | Maintains | Buy → Buy | — | $77.03 | $89.66 | +16.4% | +5.7% | -4.1% | +0.6% | +2.8% | +1.7% |
| Nov 13 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $72.49 | $71.43 | -1.5% | -1.0% | +0.5% | -1.1% | +1.2% | -0.1% |
| Aug 28 | Citigroup | Downgrade | Buy → Neutral | — | $74.11 | $62.27 | -16.0% | -12.9% | +4.4% | -3.1% | +2.8% | +1.3% |
| Aug 28 | Baird | Maintains | Outperform → Outperform | — | $74.11 | $62.27 | -16.0% | -12.9% | +4.4% | -3.1% | +2.8% | +1.3% |
| Aug 28 | Stifel | Maintains | Buy → Buy | — | $74.11 | $62.27 | -16.0% | -12.9% | +4.4% | -3.1% | +2.8% | +1.3% |
| Aug 28 | Piper Sandler | Maintains | Overweight → Overweight | — | $74.11 | $62.27 | -16.0% | -12.9% | +4.4% | -3.1% | +2.8% | +1.3% |
| Aug 28 | JP Morgan | Maintains | Neutral → Neutral | — | $74.11 | $62.27 | -16.0% | -12.9% | +4.4% | -3.1% | +2.8% | +1.3% |
| Aug 28 | Wells Fargo | Maintains | Overweight → Overweight | — | $74.11 | $62.27 | -16.0% | -12.9% | +4.4% | -3.1% | +2.8% | +1.3% |
| Aug 28 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $74.11 | $62.27 | -16.0% | -12.9% | +4.4% | -3.1% | +2.8% | +1.3% |
| Aug 28 | Needham | Maintains | Buy → Buy | — | $74.11 | $62.27 | -16.0% | -12.9% | +4.4% | -3.1% | +2.8% | +1.3% |
| Jul 16 | Mizuho | Maintains | Outperform → Outperform | — | $72.20 | $73.10 | +1.2% | +0.7% | +0.8% | -0.9% | -1.8% | +2.4% |
| Jun 17 | Needham | Upgrade | Hold → Buy | — | $69.74 | $70.34 | +0.9% | -1.4% | +1.5% | -0.5% | +0.1% | +2.0% |
| May 30 | Wells Fargo | Maintains | Overweight → Overweight | — | $79.96 | $71.98 | -10.0% | -14.6% | -1.9% | -0.1% | +0.8% | +5.6% |
| May 30 | Needham | Maintains | Hold → Hold | — | $79.96 | $71.98 | -10.0% | -14.6% | -1.9% | -0.1% | +0.8% | +5.6% |
| May 30 | Baird | Maintains | Outperform → Outperform | — | $79.96 | $71.98 | -10.0% | -14.6% | -1.9% | -0.1% | +0.8% | +5.6% |
| May 30 | JP Morgan | Downgrade | Overweight → Neutral | — | $79.96 | $71.98 | -10.0% | -14.6% | -1.9% | -0.1% | +0.8% | +5.6% |
| May 30 | Piper Sandler | Maintains | Overweight → Overweight | — | $79.96 | $71.98 | -10.0% | -14.6% | -1.9% | -0.1% | +0.8% | +5.6% |
| May 22 | Needham | Maintains | Hold → Hold | — | $79.37 | $79.37 | +0.0% | -0.1% | -0.6% | +2.2% | -0.6% | -0.2% |
| Mar 7 | Needham | Maintains | Hold → Hold | — | $90.98 | $86.18 | -5.3% | -6.6% | -6.0% | +1.4% | -2.4% | -1.7% |
| Mar 7 | Baird | Maintains | Outperform → Outperform | — | $90.98 | $86.18 | -5.3% | -6.6% | -6.0% | +1.4% | -2.4% | -1.7% |
| Mar 7 | Citigroup | Maintains | Buy → Buy | — | $90.98 | $86.18 | -5.3% | -6.6% | -6.0% | +1.4% | -2.4% | -1.7% |
| Mar 7 | Stifel | Maintains | Buy → Buy | — | $90.98 | $86.18 | -5.3% | -6.6% | -6.0% | +1.4% | -2.4% | -1.7% |
| Mar 7 | Piper Sandler | Maintains | Overweight → Overweight | — | $90.98 | $86.18 | -5.3% | -6.6% | -6.0% | +1.4% | -2.4% | -1.7% |
| Mar 7 | JP Morgan | Maintains | Overweight → Overweight | — | $90.98 | $86.18 | -5.3% | -6.6% | -6.0% | +1.4% | -2.4% | -1.7% |
| Dec 6 | Needham | Maintains | Hold → Hold | — | $103.23 | $99.39 | -3.7% | -4.4% | +0.6% | -0.2% | +0.2% | -2.6% |
| Dec 6 | Wells Fargo | Maintains | Overweight → Overweight | — | $103.23 | $99.39 | -3.7% | -4.4% | +0.6% | -0.2% | +0.2% | -2.6% |
| Dec 6 | Citigroup | Maintains | Buy → Buy | — | $103.23 | $99.39 | -3.7% | -4.4% | +0.6% | -0.2% | +0.2% | -2.6% |
| Dec 6 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $103.23 | $99.39 | -3.7% | -4.4% | +0.6% | -0.2% | +0.2% | -2.6% |
| Mar 13 | JP Morgan | Upgrade | Neutral → Overweight | — | $101.54 | $103.50 | +1.9% | +0.8% | -0.8% | -0.8% | +0.1% | +1.4% |
| Mar 1 | Mizuho | Maintains | Buy → Buy | — | $93.60 | $102.04 | +9.0% | +9.2% | +0.6% | -1.3% | +0.4% | +0.2% |
| Mar 1 | JP Morgan | Maintains | Neutral → Neutral | — | $93.60 | $102.04 | +9.0% | +9.2% | +0.6% | -1.3% | +0.4% | +0.2% |
| Mar 1 | Piper Sandler | Maintains | Overweight → Overweight | — | $93.60 | $102.04 | +9.0% | +9.2% | +0.6% | -1.3% | +0.4% | +0.2% |
| Mar 1 | Stifel | Maintains | Buy → Buy | — | $93.60 | $102.04 | +9.0% | +9.2% | +0.6% | -1.3% | +0.4% | +0.2% |
| Jan 12 | Piper Sandler | Maintains | Overweight → Overweight | — | $95.13 | $96.08 | +1.0% | +0.9% | -0.2% | -1.1% | +1.8% | +0.5% |
| Dec 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $85.27 | $84.61 | -0.8% | -0.8% | -0.9% | +2.2% | +0.7% | -2.9% |
No insider trades available.
8-K · 8.01
!! High
The Cooper Companies, Inc. -- 8-K 8.01: Material Event / Announcement
Jun 4
8-K · 5.02
!!! Very High
The Cooper Companies, Inc. -- 8-K 5.02: Executive Change
Cooper Companies appointed Paul Keel as an independent director, strengthening board governance and oversight of the medical device company's operations.
May 4
8-K
Unknown — 8-K Filing
I cannot provide a meaningful analysis because the filing summary provided is incomplete and contains only technical metadata rather than substantive business information about Cooper-Standard Holdings or the actual 8-K content.
Apr 8
8-K
The Cooper Companies, Inc. -- 8-K Filing
Cooper Companies reported Q1 2026 revenue of $1.024 billion, up 6% year-over-year (3% organic growth), demonstrating modest but steady expansion in its medical device business.
Mar 5
8-K
The Cooper Companies, Inc. -- 8-K Filing
Cooper Companies amended its 2024 Credit Agreement to align provisions with its 2021 Loan Agreement and eliminate credit spread adjustments, streamlining its debt structure.
Feb 4
Institutional (13F) — Top 5
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Brant Point Investment Management Llc | 63,312 | $5M | Reduced | Dec 2025 |
| 2 | Crystal Rock Capital Management | 70,830 | $5M | Reduced | Mar 2026 |
| 3 | Ferguson Wellman Capital Management, Inc | 3,340 | $239K | — | Mar 2026 |
| 4 | First Long Island Investors, Llc | 2,818 | $231K | New | Dec 2025 |
| 5 | Byrne Asset Management Llc | 300 | $21K | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$13.18B
Enterprise Value
$15.53B
P/E (TTM)
35.25x
Forward P/E
14.28x
PEG Ratio
-8.16x
P/B
1.60x
P/S
3.22x
P/FCF
30.39x
EV/EBITDA
14.74x
Shares Out
200.0M
Financials (TTM)
Revenue
$4.09B
Net Income
$374.9M
EBITDA
$1.05B
Free Cash Flow
$433.7M
Op Cash Flow
$796.1M
EPS Basic
$1.88
EPS Diluted
$1.87
EPS Forward
$4.62
Gross Margin
60.7%
Op Margin
16.7%
Net Margin
9.2%
Balance Sheet
Total Assets
$12.39B
Total Liab.
$4.16B
Total Equity
$8.24B
Cash
$110.6M
LT Debt
$2.46B
Book Value/Sh
$41.20
Debt/Equity
0.34x
Current Ratio
1.89
Quick Ratio
1.13
Returns & Growth
ROE
4.8%
ROA
3.2%
ROIC
4.0%
Rev Growth YoY
+5.1%
EPS Growth YoY
-4.6%
Price Returns
2W
+1.4%
1M
-2.7%
3M
-26.8%
6M
-21.5%
12M
-10.4%
Technicals
52W High
$84.32
52W Low
$58.98
50d MA
$64.29
200d MA
$72.66
RSI (14)
63.70
ATR (14)
$1.71
Beta
1.07
Avg Volume
3.2M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
2
Ex-Div Date
Jul 26, 2023
Analyst Price Targets
Consensus
$93.86
High
$100.00
Low
$73.00
Median
$98.00
Data updated apr 25, 2026 2:38am
· Source: financialmodelingprep.com